Ruth Y Lan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ruth Y Lan

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer Research|March 24, 2021

Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor ModelsJoseph R Campbell, Bryan R McDonald, Paul B Mesko, et al.

Cancer Discovery|April 2, 2024

IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor ImmunityKelly D Moynihan, Manu P Kumar, Hussein Sultan, et al.

The Journal of Clinical Investigation|February 5, 2020

A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T Freeman, Thomas R Nirschl, Daniel H Hovelson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer Research|March 24, 2021

Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor ModelsJoseph R Campbell, Bryan R McDonald, Paul B Mesko, et al.

Cancer Discovery|April 2, 2024

IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor ImmunityKelly D Moynihan, Manu P Kumar, Hussein Sultan, et al.

The Journal of Clinical Investigation|February 5, 2020

A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T Freeman, Thomas R Nirschl, Daniel H Hovelson, et al.

Pageof 2